168 related articles for article (PubMed ID: 16403216)
41. Telmisartan-Induced Myotoxicity in Patients with Essential Hypertension.
Kara SC; Canpolat U
Turk Kardiyol Dern Ars; 2024 Apr; 52(3):217-219. PubMed ID: 38573089
[TBL] [Abstract][Full Text] [Related]
42. N-Benzylindole-2-carboxylic acids: potent functional antagonists of the CCR2b chemokine receptor.
Kettle JG; Faull AW; Barker AJ; Davies DH; Stone MA
Bioorg Med Chem Lett; 2004 Jan; 14(2):405-8. PubMed ID: 14698169
[TBL] [Abstract][Full Text] [Related]
43. Molecular docking, molecular dynamics, and
Alnajjar R; Mostafa A; Kandeil A; Al-Karmalawy AA
Heliyon; 2020 Dec; 6(12):e05641. PubMed ID: 33294721
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and evaluation of new designed multiple ligands directed towards both peroxisome proliferator-activated receptor-γ and angiotensin II type 1 receptor.
Meyer M; Foulquier S; Dupuis F; Flament S; Grimaud L; Henrion D; Lartaud I; Monard G; Grillier-Vuissoz I; Boisbrun M
Eur J Med Chem; 2018 Oct; 158():334-352. PubMed ID: 30223121
[TBL] [Abstract][Full Text] [Related]
45. Divergent Spatiotemporal Interaction of Angiotensin Receptor Blocking Drugs with Angiotensin Type 1 Receptor.
Singh KD; Unal H; Desnoyer R; Karnik SS
J Chem Inf Model; 2018 Jan; 58(1):182-193. PubMed ID: 29195045
[TBL] [Abstract][Full Text] [Related]
46. Efficacy and Safety of Angiotensin Receptor Blockers in a Pre-Clinical Model of Arrhythmogenic Cardiomyopathy.
Landim-Vieira M; Kahmini AR; Engel M; Cannon EN; Amat-Alarcon N; Judge DP; Pinto JR; Chelko SP
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430389
[TBL] [Abstract][Full Text] [Related]
47. Antagonistic effects of extracts from Artemisia rupetris L. and Leontopodium leontopodioides to CC chemokine receptor 2b (CCR2b).
Yu QW; Hu J; Wang H; Chen X; Zhao F; Gao P; Yang QB; Sun DD; Zhang LY; Yan M
Chin J Nat Med; 2016 May; 14(5):363-9. PubMed ID: 27478099
[TBL] [Abstract][Full Text] [Related]
48. Nuclear Receptors in the Pathogenesis and Management of Inflammatory Bowel Disease.
Ning L; Lou X; Zhang F; Xu G
Mediators Inflamm; 2019; 2019():2624941. PubMed ID: 30804707
[TBL] [Abstract][Full Text] [Related]
49. Angiotensin II receptor antagonists (AT
van Zwieten PA
Neth Heart J; 2006 Nov; 14(11):381-387. PubMed ID: 25696573
[TBL] [Abstract][Full Text] [Related]
50. Structure of the Angiotensin receptor revealed by serial femtosecond crystallography.
Zhang H; Unal H; Gati C; Han GW; Liu W; Zatsepin NA; James D; Wang D; Nelson G; Weierstall U; Sawaya MR; Xu Q; Messerschmidt M; Williams GJ; Boutet S; Yefanov OM; White TA; Wang C; Ishchenko A; Tirupula KC; Desnoyer R; Coe J; Conrad CE; Fromme P; Stevens RC; Katritch V; Karnik SS; Cherezov V
Cell; 2015 May; 161(4):833-44. PubMed ID: 25913193
[TBL] [Abstract][Full Text] [Related]
51. Proposed new score to rate the strength of evidence and its application to large-scale clinical trials of angiotensin-receptor blockers.
Yamazaki T
Circ J; 2006 Sep; 70(9):1155-8. PubMed ID: 16936428
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of angiotensin II receptor blockers for drug formulary using objective scoring analytical tool.
Lim TM; Ibrahim MI
Pharm Pract (Granada); 2012 Jul; 10(3):136-42. PubMed ID: 24155829
[TBL] [Abstract][Full Text] [Related]
53. Synthetic nanobodies as angiotensin receptor blockers.
McMahon C; Staus DP; Wingler LM; Wang J; Skiba MA; Elgeti M; Hubbell WL; Rockman HA; Kruse AC; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2020 Aug; 117(33):20284-20291. PubMed ID: 32753386
[TBL] [Abstract][Full Text] [Related]
54. A comprehensive quality control and cost comparison study of branded and generic angiotensin receptor blockers.
Sharma AK; Rastogi S; Ali F; Yadav AP; Goyal RK
Saudi Pharm J; 2024 Mar; 32(3):101985. PubMed ID: 38380162
[TBL] [Abstract][Full Text] [Related]
55. Electrosmog and autoimmune disease.
Marshall TG; Heil TJR
Immunol Res; 2017 Feb; 65(1):129-135. PubMed ID: 27412293
[TBL] [Abstract][Full Text] [Related]
56. Development and Verification of Time-Series Deep Learning for Drug-Induced Liver Injury Detection in Patients Taking Angiotensin II Receptor Blockers: A Multicenter Distributed Research Network Approach.
Heo S; Yu JY; Kang EA; Shin H; Ryu K; Kim C; Chegal Y; Jung H; Lee S; Park RW; Kim K; Hwangbo Y; Lee JH; Park YR
Healthc Inform Res; 2023 Jul; 29(3):246-255. PubMed ID: 37591680
[TBL] [Abstract][Full Text] [Related]
57. New insights into the management of hypertension and cardiovascular risk with Angiotensin receptor blockers: observational studies help us?
Goudev A
Open Cardiovasc Med J; 2014; 8():35-42. PubMed ID: 24847388
[TBL] [Abstract][Full Text] [Related]
58. Asymptotically exact solution of a local copper-oxide model.
Zhang GM; Yu L
Phys Rev Lett; 1994 Apr; 72(15):2474-2477. PubMed ID: 10055889
[No Abstract] [Full Text] [Related]
59. Asymptotically exact solution of the multichannel resonant-level model.
Zhang GM; Su ZB; Yu L
Phys Rev B Condens Matter; 1994 Mar; 49(11):7759-7762. PubMed ID: 10009525
[No Abstract] [Full Text] [Related]
60. Asymptotically exact mean-field theory for the Anderson model including double occupancy.
Holm J; Kree R; Schönhammer K
Phys Rev B Condens Matter; 1993 Aug; 48(8):5077-5089. PubMed ID: 10009021
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
